Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

Clinical trial NCT05966272 · COMPLETED

Trial details

NCT number: NCT05966272
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2023-08-12
Primary completion: 2024-09-24
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.